Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms
about
Dynamic Change in p63 Protein Expression during Implantation of Urothelial Cancer Clusters.p63 expression defines a lethal subset of muscle-invasive bladder cancers.Induction of ΔNp63 by the newly identified keratinocyte-specific transforming growth factor β Signaling Pathway with Smad2 and IκB Kinase α in squamous cell carcinoma.Distinct expression profiles of p63 variants during urothelial development and bladder cancer progressionExpression and regulation of the ΔN and TAp63 isoforms in salivary gland tumorigenesis clinical and experimental findings.The expression of p63 in bladder cancer vs. chronic bilharzial bladder.The prognostic significance of p53, p63 and her2 expression in non-muscle-invasive bladder cancer in relation to treatment with bacille Calmette-Guerin.Role of p63 in Development, Tumorigenesis and Cancer ProgressionThe p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.Upregulation of cell adhesion through delta Np63 silencing in human 5637 bladder cancer cells.Sequence variant on 3q28 and urinary bladder cancer risk: findings from the Los Angeles-Shanghai bladder case-control study.MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression.Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.Molecular genetics of bladder cancer: Emerging mechanisms of tumor initiation and progression.Management of upper urinary tract urothelial carcinoma.The role of p63 in cancer, stem cells and cancer stem cells.Expression of p63 in reactive hyperplasias and malignant lymphomas.Expression of aberrant beta-catenin and impaired p63 in craniopharyngiomas.Expression of the tumor suppressor protein 14-3-3 sigma is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition.Molecular determinants of Akt-induced keratinocyte transformation.A double dealing tale of p63: an oncogene or a tumor suppressor.Understanding the biology of urothelial cancer metastasis.
P2860
Q30403508-CC5EC84A-AB23-407C-92C0-0026F9FABE2DQ34131185-4F7284E6-F6CD-40E8-9D1C-ACC83BB00E33Q34411687-68AA3564-EF80-43C4-B75F-B3966AE0B5B8Q34755858-AB1C456C-0C9D-46FA-93AD-9D3C6B7AB3D7Q35070144-7A708E39-7D4A-4E89-8489-9C53C3FF8D86Q35643084-114281DC-F471-4A64-8379-E7E7A27DBB39Q36038105-C69349C6-6DC2-4113-93CB-AF40CF18441BQ36284945-6F43522C-F481-419C-A627-D06E1BDBC7D2Q36579525-14F49CE4-0B69-4F40-8B10-B830B4BBD3EBQ37074167-129A07C3-488B-4C9E-A78A-31DDFADF1127Q37437754-30A82CFB-1399-4517-A3AC-0D33E46144F6Q37580204-7E9C41FB-0D80-4781-90C8-2FC06B8A31A3Q37655607-ADE2DB39-F428-47F2-A5C9-53890D7564B4Q37770783-63CB735B-2FA6-43C6-AD2A-E2975263097DQ37812609-DFBD9BF7-EAFB-49FD-84EB-9F6C9C835E1CQ37858470-56FA0694-3881-4060-A921-5B629CFE5E42Q41853269-E9F9151D-2800-49AC-A110-923E0A09D05CQ42466768-664EA837-34CC-4251-81B3-0A575DDBE466Q44737220-28E17B51-995B-4266-B710-D44FEDDA9513Q46772716-70DA5815-713D-4D85-9CD5-10FE4D3C5C95Q47702782-C318502C-E8D6-4549-B007-905FE1EAD636Q55126311-58229C9B-29E3-4E42-9106-FFA44E4F5968
P2860
Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Impaired Delta Np63 expression ...... otypes of urothelial neoplasms
@en
type
label
Impaired Delta Np63 expression ...... otypes of urothelial neoplasms
@en
prefLabel
Impaired Delta Np63 expression ...... otypes of urothelial neoplasms
@en
P2093
P2860
P356
P1476
Impaired Delta Np63 expression ...... otypes of urothelial neoplasms
@en
P2093
S Kawakami
T Takizawa
Y Kageyama
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600764
P407
P577
2003-03-01T00:00:00Z
P5875
P6179
1014868759